MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-06-0001834
Surmount Formulations Private Limited
Surmount Formulations Private Limited - pharma in Ankleshwar, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.09 Lakh
▲ 72% YoY
Net profit · FY 2025
₹1.87 Lakh
Net margin 45.7%
EBITDA · FY 2025
₹2.58 Lakh
EBITDA margin 63.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹5 Cr
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Surmount Formulations Private Limited
Data last updated:
Surmount Formulations Private Limited is a private limited company based in Ankleshwar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2020PTC116901. Its GSTIN is 24ABECS5472N1ZV (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Dhirendra Maganlal Mehta and Kavit Dhirendrakumar Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. F – 16 – 17 – 18/B Plot 73 Roshni Plaza Shopping Center Station Road, Ankleshwar, Gujarat, India – 393002.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.09 Lakh, a growth of 72% compared to the previous year. For the same year it recorded a net profit of ₹1.87 Lakh (net margin 45.7%) and EBITDA of ₹2.58 Lakh (EBITDA margin 63.2%). Revenue has declined at a compounded annual rate (CAGR) of 62% over three years.
As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹5 Cr on record.
Surmount Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0001834).
Company details
CIN U24304GJ2020PTC116901
Registration Number 116901
Incorporation Date 29 September 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-GJ-06-0001834
Recognitions & Rankings of Surmount Formulations
Contact details
Surmount Formulations Private Limited's registered office is in Ankleshwar, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. F – 16 – 17 – 18/B Plot 73 Roshni Plaza Shopping Center Station Road, Ankleshwar, Gujarat, India – 393002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Surmount Formulations Private Limited, buy the company report.
Comprehensive company report
Surmount Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Surmount Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Surmount Formulations Private Limited
FY 2025 filings availableSurmount Formulations Private Limited reported revenue of ₹4.09 Lakh (up 72% YoY) for FY 2025.
Revenue · FY 2025
₹4.09 Lakh ▲ 72%
Net profit · FY 2025
₹1.87 Lakh margin 45.7%
EBITDA · FY 2025
₹2.58 Lakh margin 63.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 72%
3 years · compounded
▼ 62%
EBITDA CAGR growth
1 year
▲ 886%
3 years · compounded
▼ 38%
Revenue rose 72% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 62%. EBITDA rose 886% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.87 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 63.2% | ||||
| Net Profit Margin | 45.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surmount Formulations Private Limited, buy the company report.
Board of directors of Surmount Formulations Private Limited
Surmount Formulations has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhirendra Maganlal Mehta Also directs: Surmount Laboratories Limited | Director | 29 Sep 2020 | 6 Years 1 Months | Current |
| Kavit Dhirendrakumar Mehta Also directs: Surmount Laboratories Limited | Director | 29 Sep 2020 | 6 Years 1 Months | Current |
Auditor
Surmount Formulations Private Limited is audited by P.V. JAIN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.V. JAIN & CO | FY 2023 | 149773 |
Shareholding
The shareholding of Surmount Formulations Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Surmount Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2021 | 100436883 | Others | ₹5 Cr | Satisfied |
To see the full charge records of Surmount Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Surmount Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surmount Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Surmount Formulations Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Surmount Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ABECS5472N1ZV | Gujarat | Active | 18 Oct 2020 |
To see the full GST registrations and return filing status of Surmount Formulations Private Limited, buy the company report.
Recent activity
Surmount Formulations Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Dhirendra Maganlal Mehta was appointed as Director on 29 Sep 2020.
AGM
Surmount Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 25 Mar 2021 via Charge ID 100436883 with Others was fully satisfied on 24 Jun 2025.
Filing
Surmount Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100436883 was registered on 25 Mar 2021.
Appointed
Dhirendra Maganlal Mehta was appointed as Director.
Appointed
Kavit Dhirendrakumar Mehta was appointed as Director.
Incorporation
29 Sep 2020
Surmount Formulations Private Limited was registered on 29 Sep 2020 with Roc Ahmedabad & aged 6 years 1 month as per MCA records.
Frequently asked questions
Surmount Formulations is an active private limited company based in Ankleshwar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2020 (6+ years old) and is registered under CIN U24304GJ2020PTC116901.
Surmount Formulations has 2 current directors:
- Dhirendra Maganlal Mehta - Director
- Kavit Dhirendrakumar Mehta - Director
The latest financial statements of Surmount Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Surmount Formulations is 24ABECS5472N1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Surmount Formulations is U24304GJ2020PTC116901. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surmount Formulations was incorporated on 29 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dhirendra Maganlal Mehta was appointed as Director on 29 Sep 2020. Kavit Dhirendrakumar Mehta was appointed as Director on 29 Sep 2020.
Yes, Surmount Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-06-0001834).
The registered office of Surmount Formulations is at Shop No. F – 16 – 17 – 18B Plot 73 Roshni Plaza Shopping Center Station Road, Ankleshwar, Gujarat, India – 393002.
Surmount Formulations operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages